![]() ![]() This spring, Rochester will dedicate the new Clinical and Translational Science Building (see page 28). ![]() Congress and the National Institutes of Health (NIH) are seeking to change that, and Rochester is helping to lead the way. The importance of harnessing science for practical solutions to health problems may seem obvious, but in recent decades some policymakers have argued that the nation’s biomedical focus has drifted away from research that’s directly applicable to patients and human disease. “All of our studies have related, in one way or another, to the question, ‘How can we improve treatment for patients with heart disease?’ ” Moss says. One concern unifies his years of research. For more than 20 years, he has led a team of cardiologists in reducing potentially fatal cardiac arrhythmias through advances in drug treatment, such as beta blockers, and through devices like implantable cardioverter defibrillators. The world’s foremost expert on long QT syndrome-a condition that puts patients at risk for sudden cardiac arrest-Moss was one of the researchers who discovered the genes responsible for the disorder. Moss has done that by collaborating with other cardiologists, geneticists, epidemiologists, biostatisticians, and a host of others he has involved thousands of patients who have volunteered to take part in his teams’ research-all in a quest to better understand heart disease and to develop more effective therapies for cardiac patients. “I wanted to see patients in a clinical setting, and advance the science of cardiology,” Moss says of his aspirations for a career that, five decades on, has contributed to saving the lives of countless people. “Under One Roof”: See the building’s floor plan (Illustration: Steve Boerner for Rochester Review) ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |